Literature DB >> 21334329

Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line.

Yixue Gu1, Shasha Fan, Yan Xiong, Bo Peng, Guopei Zheng, Yanhui Yu, Yongmei Ouyang, Zhimin He.   

Abstract

To explore the mechanisms of chemotherapy resistance, we previously established a multi-drug resistant cell line, Tca8113/Pingyangmycin (Tca8113/PYM) and identified differential expression in known genes and ESTs using microarray analysis. From among those ESTs we have now identified a novel gene producing an mRNA of 1834 nucleotides translated into a protein having 235 amino acids. This gene was denominated as tongue cancer resistance-associated protein 1 gene (TCRP1, accession number: EF363480). We further determined its functional characteristics. The results demonstrate that TCRP1 mediates a specific resistance to cisplatin in Tca8113 cells by reducing the cisplatin-induced apoptosis. This suggests that TCRP1 might be a novel molecular target to develop agents to reverse cisplatin-induced chemoresistance. Crown
Copyright © 2011. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21334329     DOI: 10.1016/j.febslet.2010.12.045

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  TCRP1 contributes to cisplatin resistance by preventing Pol β degradation in lung cancer cells.

Authors:  Xiaorong Liu; Chengkun Wang; Yixue Gu; Zhijie Zhang; Guopei Zheng; Zhimin He
Journal:  Mol Cell Biochem       Date:  2014-09-27       Impact factor: 3.396

2.  Proteomic analyses of Sirt1-mediated cisplatin resistance in OSCC cell line.

Authors:  Ping Xiong; Yu-xuan Li; Yun-tao Tang; Hong-gang Chen
Journal:  Protein J       Date:  2011-10       Impact factor: 2.371

3.  Exploring new gene integration sites for gene knock-in by gene-trapping strategy.

Authors:  Isamu Nanchi; Yuki Yoshimura; Kazuomi Nakamura; Yusaku Masago; Tetsuya Ohbayashi; Tomohiko Okuda
Journal:  Transgenic Res       Date:  2015-03-31       Impact factor: 2.788

4.  TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway.

Authors:  Yixue Gu; Shasha Fan; Binjie Liu; Guopei Zheng; Yanhui Yu; Yongmei Ouyang; Zhimin He
Journal:  Mol Cell Biochem       Date:  2011-05-21       Impact factor: 3.396

5.  TCRP1 expression is associated with platinum sensitivity in human lung and ovarian cancer cells.

Authors:  Xiaorong Liu; Meiling Feng; Guopei Zheng; Yixue Gu; Chengkun Wang; Zhimin He
Journal:  Oncol Lett       Date:  2016-12-27       Impact factor: 2.967

6.  TCRP1 activated by mutant p53 promotes NSCLC proliferation via inhibiting FOXO3a.

Authors:  Hao Liu; Xiaoting Jia; Kai Luo; Xiangzhou Chen; Zhijie Zhang; Danyang Chen; Yixue Gu; Zhimin He; Guopei Zheng
Journal:  Oncogenesis       Date:  2022-04-22       Impact factor: 6.524

7.  TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer.

Authors:  Xiaoting Jia; Zhijie Zhang; Kai Luo; Guopei Zheng; Minying Lu; Ying Song; Hao Liu; Huisi Qiu; Zhimin He
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

8.  Microarray-assisted pathway analysis identifies MT1X & NFκB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinoma.

Authors:  Bo Peng; Yixue Gu; Yan Xiong; Guopei Zheng; Zhimin He
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

9.  TCRP1 promotes NIH/3T3 cell transformation by over-activating PDK1 and AKT1.

Authors:  C Wang; H Liu; Q Qiu; Z Zhang; Y Gu; Z He
Journal:  Oncogenesis       Date:  2017-04-24       Impact factor: 7.485

10.  Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1).

Authors:  Yixue Gu; Zhijie Zhang; Jiang Yin; Jiahui Ye; Yin Song; Hao Liu; Yan Xiong; Minying Lu; Guopei Zheng; Zhimin He
Journal:  J Exp Clin Cancer Res       Date:  2017-08-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.